← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 15, 2019Last known activity
Apr 15, 2019
Acquired by Gilead Sciences on Dec 10, 2020
Timeline
2010s
- Jan 1, 2010
MYR Pharmaceuticals GmbH— Founded
2020s
- Dec 10, 2020
Gilead Sciences— Acquired By
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT03852719Lead sponsorPhase 3Apr 15, 2019
- NCT03852433Lead sponsorPhase 2Apr 15, 2019
Details
- Founded
- Burgwedel, DE Jan 1, 2010
- Last known activity
- Apr 15, 2019